REC-4881
Familial Adenomatous Polyposis (FAP)
Key Facts
Indication
Familial Adenomatous Polyposis (FAP)
Phase
Phase 1b/2
Status
Active
Company
About Recursion Pharmaceuticals
Recursion Pharmaceuticals aims to decode biology and radically improve lives by applying artificial intelligence and automation to drug discovery. Its core asset is the Recursion OS, a comprehensive platform that generates and analyzes petabytes of proprietary biological data to fuel an internal pipeline of potential first-in-class and best-in-class therapies. The company has advanced several programs into clinical trials, secured strategic partnerships with industry leaders, and is building one of the most powerful supercomputers in biopharma to scale its operations.
View full company profile